# Targeting IRAK4 in Chronic Lymphocytic Leukemia

> **NCT07741695** · — · NOT_YET_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 50 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia (CLL)

## Interventions

- **PROCEDURE:** Peripheral blood sample collection

## Key facts

- **NCT ID:** NCT07741695
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07741695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07741695, "Targeting IRAK4 in Chronic Lymphocytic Leukemia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07741695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*